EOCRC Treatment Delays: Language Barriers Are a Modifiable Risk Factor: JAMA Oncology | June 2026

• Early age–onset colorectal cancer is increasing globally and is now a major public health concern, especially because many patients present before routine screening age.

• This population-based Texas Cancer Registry study included more than 112,000 patients with colorectal cancer, including over 12,000 patients with early age–onset colorectal cancer.

• Early age–onset colorectal cancer accounted for approximately 11% of all colorectal cancer cases in this cohort.

• Patients with early age–onset colorectal cancer were more likely to be Hispanic, less likely to be White, and more likely to have left-sided or rectal tumors.

• Early age–onset colorectal cancer patients were also more likely to present with advanced-stage disease, reinforcing the need for earlier symptom recognition and timely diagnostic pathways.

• Treatment delay was defined as more than 6 weeks from tissue diagnosis to initiation of definitive therapy.

• Treatment delays were independently associated with worse overall survival in colorectal cancer.

• Importantly, treatment delay remained significantly associated with worse survival even among patients with early age–onset colorectal cancer.

• Higher social vulnerability was also associated with poorer survival, highlighting the role of social determinants of health in cancer outcomes.

• Language barrier emerged as a key modifiable factor associated with treatment delay in early age–onset colorectal cancer.

• After adjusting for demographic and clinical factors, patients with language barriers had a significantly higher likelihood of delayed treatment.

• This finding is clinically important because language barriers can be addressed through structured navigation, professional interpretation services, multilingual education, and culturally sensitive cancer care pathways.

• The study shifts attention from biology alone to healthcare delivery, showing that outcomes in early age–onset colorectal cancer are influenced by access, communication, and system-level equity.

• For clinicians, the message is clear: once colorectal cancer is diagnosed in a young patient, treatment planning must be rapid, coordinated, and barrier-sensitive.

• Oncology systems should track time from diagnosis to treatment initiation as a quality metric, especially in younger and socially vulnerable patients.

Bottom line: Early age–onset colorectal cancer patients often present with higher-risk clinical features, but treatment delays further worsen outcomes. Language barriers are a practical, modifiable target for improving timely care and survival.